Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) remains a challenging malignant tumor with poor prognosis and limited treatment methods worldwide, and most patients are at a locally advanced stage at diagnosis. High recurrence and metastasis rates remain the main factors leading to the failure...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wenwu, Wang, Chenghao, Wu, Lei, Wan, Gang, Li, Baisen, Han, Yongtao, Li, Haojun, Leng, Xuefeng, Du, Kunyi, Chen, Haijun, Wang, Qifeng, Peng, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201912/
https://www.ncbi.nlm.nih.gov/pubmed/35720312
http://dx.doi.org/10.3389/fimmu.2022.853922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201912/
https://www.ncbi.nlm.nih.gov/pubmed/35720312
http://dx.doi.org/10.3389/fimmu.2022.853922

Ejemplares similares